Ä¢¹½ÊÓƵAPP

MEDFORD, Mass. and TOKYO, July 1, 2019 /PRÄ¢¹½ÊÓƵAPPwire/ -- Seventh Sense Biosystems, Inc. (7SBio), makers of TAPâ„¢, the world's first push-button blood collection device, and Miraca Holdings Inc. or Miraca ($MRCHF), the largest commercial clinical laboratory in Japan, announced today that the companies have entered into a strategic investment and distribution agreement. Under the terms, Miraca will become a strategic investor in 7SBio, as well as use and distribute TAP products in Japan.

The TAP device is positioned on a patient's upper arm, and with just a 'tap' blood is collected virtually painlessly. The intent is to enable more convenient and less expensive blood collection than traditional methods. TAP is FDA 510(k) cleared and has a CE Mark.

"We are excited to partner with the leading clinical laboratory in Japan in order to enable more patients to use TAP," said Dr. Robert Langer, 7SBio Co-Founder and one of 10 Institute Professors at MIT (MIT's highest honor).

For up-to-date information, go to or to .

About Seventh Sense

Seventh Sense Biosystems has designed and developed TAPâ„¢, the world's first push-button blood collection device. It makes the process simple, convenient, and virtually painless. $50 billion is spent annually on diagnostics and consumers are demanding more from the healthcare system. The company aims to create a new standard for blood collection that increases patient compliance with testing orders, leading to faster diagnoses and better outcomes. Investors in the company include Ä¢¹½ÊÓƵAPP, Polaris Partners, Newpath Partners, aMoon, LabCorp ($LH), and Novartis ($NVS).

About the Miraca Group

Miraca Holdings, a Japan-based holding company in the healthcare sector listed on the Tokyo Stock Exchange, consists of three segments: (i) development, manufacture, and commercialization of in vitro diagnostics, (ii) clinical laboratory testing, and (iii) other healthcare related businesses, which are conducted by its subsidiaries and affiliates including Fujirebio Inc,. a leading supplier of in vitro diagnostics in Japan, and SRL, Inc., Japan's largest commercial laboratory.